Screener
Contineum Therapeutics, Inc. CTNM Q4 2025 Annual earnings
Reported March 5, 2026 · Before market open
EPS-$0.49Beat by $0.01
Revenue estimate$7.5M
EPS estimate-$0.50
Next report
Oct 29, 2026 (in a month)Revenue estimate$5.7M
EPS estimate-$0.45
Versus estimates
Diluted EPS
FAQ
- When did Contineum Therapeutics, Inc. report Q4 2025 earnings?
- Contineum Therapeutics, Inc. (CTNM) reported Q4 2025 earnings on March 5, 2026 before market open.
- What were Contineum Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Contineum Therapeutics, Inc. reported eps of $-0.49 for Q4 2025.
- Did Contineum Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.50 by $0.01.
- How did Contineum Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 12.5% from $-0.56.
- Where can I find Contineum Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-26-015159) and the 10-K periodic report (0001628280-26-015165) directly on SEC EDGAR. The filing index links above go to sec.gov.
